Connection

Allen Kaplan to Kallikreins

This is a "connection" page, showing publications Allen Kaplan has written about Kallikreins.
Connection Strength

2.221
  1. Specific Targeting of Plasma Kallikrein for Treatment of Hereditary Angioedema: A Revolutionary Decade. J Allergy Clin Immunol Pract. 2022 03; 10(3):716-722.
    View in: PubMed
    Score: 0.173
  2. Hereditary angioedema: Investigational therapies and future research. Allergy Asthma Proc. 2020 11 01; 41(Suppl 1):S51-S54.
    View in: PubMed
    Score: 0.160
  3. Deficiency of plasminogen activator inhibitor 2 in plasma of patients with hereditary angioedema with normal C1 inhibitor levels. J Allergy Clin Immunol. 2016 06; 137(6):1822-1829.e1.
    View in: PubMed
    Score: 0.113
  4. Bradykinin-mediated diseases. Chem Immunol Allergy. 2014; 100:140-7.
    View in: PubMed
    Score: 0.103
  5. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II. J Allergy Clin Immunol. 2013 Aug; 132(2):470-5.
    View in: PubMed
    Score: 0.096
  6. Effect of Neurotropin on the activation of the plasma kallikrein-kinin system. Biochem Pharmacol. 1992 Mar 17; 43(6):1361-9.
    View in: PubMed
    Score: 0.088
  7. Studies of the activation and inhibition of the plasma kallikrein-kinin system. Agents Actions Suppl. 1992; 38 ( Pt 3):317-28.
    View in: PubMed
    Score: 0.087
  8. The plasma bradykinin-forming pathways and its interrelationships with complement. Mol Immunol. 2010 Aug; 47(13):2161-9.
    View in: PubMed
    Score: 0.079
  9. The bradykinin-forming cascade and its role in hereditary angioedema. Ann Allergy Asthma Immunol. 2010 Mar; 104(3):193-204.
    View in: PubMed
    Score: 0.077
  10. Treatment of episodes of hereditary angioedema with C1 inhibitor: serial assessment of observed abnormalities of the plasma bradykinin-forming pathway and fibrinolysis. Ann Allergy Asthma Immunol. 2010 Jan; 104(1):50-4.
    View in: PubMed
    Score: 0.076
  11. Studies of the cleavage of human high molecular weight kininogen by purified plasma and tissue kallikreins, and upon contact activation of plasma. Adv Exp Med Biol. 1989; 247B:317-24.
    View in: PubMed
    Score: 0.071
  12. Studies of the mechanisms of bradykinin generation in hereditary angioedema plasma. Ann Allergy Asthma Immunol. 2008 Sep; 101(3):279-86.
    View in: PubMed
    Score: 0.069
  13. Cleavage of human high-molecular weight kininogen by purified kallikreins and upon contact activation of plasma. Blood. 1988 May; 71(5):1334-40.
    View in: PubMed
    Score: 0.067
  14. Activation of plasma Hageman factor and kallikrein in ongoing allergic reactions in the skin. J Immunol. 1987 Oct 15; 139(8):2744-8.
    View in: PubMed
    Score: 0.065
  15. Study of the effect of high molecular weight kininogen upon the fluid-phase inactivation of kallikrein by C1 inhibitor. J Biol Chem. 1986 Nov 15; 261(32):14965-8.
    View in: PubMed
    Score: 0.061
  16. Distribution of plasma kallikrein between C-1 inactivator and alpha 2-macroglobulin in plasma utilizing a new assay for alpha 2-macroglobulin-kallikrein complexes. J Biol Chem. 1985 Apr 10; 260(7):4257-63.
    View in: PubMed
    Score: 0.055
  17. Immunoreactive tissue kallikrein in human serum. J Lab Clin Med. 1984 May; 103(5):731-8.
    View in: PubMed
    Score: 0.051
  18. Assessment of the role of heparan sulfate in high molecular weight kininogen binding to human umbilical vein endothelial cells. J Thromb Haemost. 2003 Nov; 1(11):2444-9.
    View in: PubMed
    Score: 0.049
  19. The cleavage and formation of activated human Hageman factor by autodigestion and by kallikrein. J Biol Chem. 1982 Feb 25; 257(4):1779-84.
    View in: PubMed
    Score: 0.044
  20. Analysis of cold activation of the contact system in hereditary angioedema with normal C1 inhibitor. Mol Immunol. 2021 08; 136:150-160.
    View in: PubMed
    Score: 0.042
  21. The mechanism by which the light chain of cleaved HMW-kininogen augments the activation of prekallikrein, factor XI and Hageman factor. Thromb Res. 1980 Oct 15; 20(2):173-89.
    View in: PubMed
    Score: 0.040
  22. sgp120 and the contact system in hereditary angioedema: A diagnostic tool in HAE with normal C1 inhibitor. Mol Immunol. 2020 03; 119:27-34.
    View in: PubMed
    Score: 0.038
  23. Initiation of plasma prorenin activation by Hageman factor-dependent conversion of plasma prekallikrein to kallikrein. Proc Natl Acad Sci U S A. 1979 Nov; 76(11):5914-8.
    View in: PubMed
    Score: 0.037
  24. Studies of binding of prekallikrein and Factor XI to high molecular weight kininogen and its light chain. Proc Natl Acad Sci U S A. 1979 Oct; 76(10):4862-6.
    View in: PubMed
    Score: 0.037
  25. Hageman factor substrates. Human plasma prekallikrein: mechanism of activation by Hageman factor and participation in hageman factor-dependent fibrinolysis. J Biol Chem. 1977 Sep 10; 252(17):6097-104.
    View in: PubMed
    Score: 0.032
  26. Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein. J Clin Invest. 1977 Jul; 60(1):18-31.
    View in: PubMed
    Score: 0.032
  27. The role of Hageman factor, prekallifrein, and high molecular weight kininogen in the generation of bradykinin and the initiation of coagulation and fibrinolysis. Monogr Allergy. 1977; 12:120-30.
    View in: PubMed
    Score: 0.031
  28. Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma. Proc Natl Acad Sci U S A. 1976 Nov; 73(11):4179-83.
    View in: PubMed
    Score: 0.030
  29. Mononuclear cell chemotactic activity of kallikrein and plasminogen activator and its inhibition by C1 inhibitor and alpha 2-macroglobulin. J Immunol. 1974 Dec; 113(6):1928-34.
    View in: PubMed
    Score: 0.027
  30. Generation of vasoactive peptide bradykinin from human umbilical vein endothelium-bound high molecular weight kininogen by plasma kallikrein. Blood. 1992 Oct 15; 80(8):1980-8.
    View in: PubMed
    Score: 0.023
  31. A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein. J Exp Med. 1972 Jan; 135(1):81-97.
    View in: PubMed
    Score: 0.022
  32. A prealbumin activator of prekallikrein. II. Derivation of activators of prekallikrein from active Hageman factor by digestion with plasmin. J Exp Med. 1971 Apr 01; 133(4):696-712.
    View in: PubMed
    Score: 0.021
  33. The kallikrein-kinin system in inflammation. Adv Exp Med Biol. 1989; 247A:125-36.
    View in: PubMed
    Score: 0.018
  34. Pathways of kinin formation and role in allergic diseases. Clin Immunol Immunopathol. 1989 Jan; 50(1 Pt 2):S41-51.
    View in: PubMed
    Score: 0.018
  35. Prekallikrein. Methods Enzymol. 1988; 163:85-95.
    View in: PubMed
    Score: 0.016
  36. Kinin formation: mechanisms and role in inflammatory disorders. Annu Rev Immunol. 1988; 6:49-83.
    View in: PubMed
    Score: 0.016
  37. Assessment of Hageman factor activation in human plasma: quantification of activated Hageman factor-C1 inactivator complexes by an enzyme-linked differential antibody immunosorbent assay. Blood. 1985 Sep; 66(3):636-41.
    View in: PubMed
    Score: 0.014
  38. Hageman factor-dependent pathways: mechanism of initiation and bradykinin formation. Fed Proc. 1983 Nov; 42(14):3123-7.
    View in: PubMed
    Score: 0.012
  39. Studies of C1 inactivator-plasma kallikrein complexes in purified systems and in plasma. J Biol Chem. 1983 May 25; 258(10):6415-21.
    View in: PubMed
    Score: 0.012
  40. Mechanisms of bradykinin generation in human plasma. Monogr Allergy. 1983; 18:272-6.
    View in: PubMed
    Score: 0.012
  41. Initiation of contact activation of human plasma. Adv Exp Med Biol. 1983; 156:45-61.
    View in: PubMed
    Score: 0.012
  42. Enzymatic activities of activated and zymogen forms of human Hageman factor (factor XII). Blood. 1982 Jul; 60(1):64-70.
    View in: PubMed
    Score: 0.011
  43. Interaction of the clotting, kinin-forming, complement, and fibrinolytic pathways in inflammation. Ann N Y Acad Sci. 1982; 389:25-38.
    View in: PubMed
    Score: 0.011
  44. The intrinsic coagulation-kinin pathway, complement cascades, plasma renin-angiotensin system, and their interrelationships. Crit Rev Immunol. 1981 Sep; 3(1):75-93.
    View in: PubMed
    Score: 0.011
  45. Bradykinin formation. Plasma and tissue pathways and cellular interactions. Clin Rev Allergy Immunol. 1998; 16(4):403-29.
    View in: PubMed
    Score: 0.008
  46. The Hageman factor dependent pathways of coagulation, fibrinolysis, and kinin-generation. Semin Thromb Hemost. 1976 Jul; 3(1):1-26.
    View in: PubMed
    Score: 0.007
  47. Activation of surface-bound Hageman factor: pre-eminent role of high molecular weight kininogen and evidence for a new factor. Adv Exp Med Biol. 1976; 70(00):285-99.
    View in: PubMed
    Score: 0.007
  48. Substrates of Hageman factor. I. Isolation and characterization of human factor XI (PTA) and inhibition of the activated enzyme by alpha 1-antitrypsin. J Exp Med. 1974 Dec 01; 140(6):1615-30.
    View in: PubMed
    Score: 0.007
  49. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation. J Clin Invest. 1974 Feb; 53(2):622-33.
    View in: PubMed
    Score: 0.006
  50. The fibrinolytic pathway of human plasma. II. The generation of chemotactic activity by activation of plasminogen proactivator. J Clin Invest. 1973 Oct; 52(10):2591-5.
    View in: PubMed
    Score: 0.006
  51. Bradykinin generation by dialysis membranes: possible role in anaphylactic reaction. J Am Soc Nephrol. 1993 Mar; 3(9):1563-9.
    View in: PubMed
    Score: 0.006
  52. The fibrinolytic pathway of human plasma. Isolation and characterization of the plasminogen proactivator. J Exp Med. 1972 Dec 01; 136(6):1378-93.
    View in: PubMed
    Score: 0.006
  53. The IgE-dependent release of a Hageman factor cleaving factor from human lung. Am J Pathol. 1986 Apr; 123(1):146-54.
    View in: PubMed
    Score: 0.004
  54. Mechanisms for Hageman factor activation and role of HMW kininogen as a coagulation cofactor. Ann N Y Acad Sci. 1981; 370:253-60.
    View in: PubMed
    Score: 0.003
  55. The use of isoelectric focusing to study components of the human plasma kinin-forming system. Ann N Y Acad Sci. 1973 Jun 15; 209:372-86.
    View in: PubMed
    Score: 0.002
  56. Plasma inhibitors of the components of the fibrinolytic pathway in man. J Clin Invest. 1973 Jun; 52(6):1394-401.
    View in: PubMed
    Score: 0.001
  57. Inhibition by C1INH of Hagemann factor fragment activation of coagulation, fibrinolysis, and kinin generation. J Clin Invest. 1973 Jun; 52(6):1402-9.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.